Liberal Arts in Russia EN-rus logo
russian flagRussian
ISSN 2305-8420 (Print)
ISSN 2312-6442 (Online)
Current Issue

The influence of anemia on the quality of life of patients with early stages of diabetic nephropathy

Liberal Arts in Russia. 2016. Vol. 5. No. 2. Pp. 191-199.
Get the full text (Russian)
Pchelin I. Y.
Saint Petersburg State University
7/9 Universitetskaya Emb., 199034 Saint Petersburg, Russia
Email: cftspbu@mail.ru
Shishkin A. N.
Saint Petersburg State University
7/9 Universitetskaya Emb., 199034 Saint Petersburg, Russia
Vasilkova O. N.
Gomel State Medical University
5 Lange St., 246000 Gomel, Belarus
Kulibaba T. G.
Saint Petersburg State University
7/9 Universitetskaya Emb., 199034 Saint Petersburg, Russia
Hudiakova N. V.
Saint Petersburg State University
7/9 Universitetskaya Emb., 199034 Saint Petersburg, Russia

Abstract

The concept of quality of life is the basis for a new paradigm of clinical medicine. Its assessment is considered to be an important instrument in determining disease severity and effectiveness of different treatment modalities. Our studies are devoted to the problem of diabetes complications especially anemia in patients with diabetic kidney disease. Anemia in subjects with diabetic nephropathy may result from various pathogenic factors including erythropoietin deficiency, iron deficiency, vitamin B12 and/or folate deficiencies, the effects of proinflammatory cytokines etc. Diabetic patients with anemia are at increased risk of cardiovascular accidents and death. The aim of this study was to assess the influence of anemia on the quality of life of patients with early stages of diabetic nephropathy. We investigated 127 patients with type 2 diabetes mellitus and early diabetic nephropathy (chronic kidney disease stages 1-3). Anemia was defined according to the World Health Organization criteria. Anemic patients were divided into three groups according to the stage of chronic kidney disease. Patients’ quality of life was assessed with SF-36 health survey. Anemic patients had lower scores of physical role functioning and emotional role functioning as compared to the patients with normal hemoglobin level, irrespective of the stage of chronic kidney disease. Patients with anemia and chronic kidney disease stage 3 had lower scores of general health perceptions, physical functioning, bodily pain, vitality and mental health than patients in the non-anemic group. Social role functioning was similar in anemic and non-anemic patients. The possible mechanisms and implications of the above mentioned findings are discussed with a medical and humanitarian perspective. The directions of further studies are proposed.

Keywords

  • • quality of life
  • • diabetes mellitus
  • • diabetic nephropathy
  • • chronic kidney disease
  • • anemia

References

  1. Novik A. A., Ionova T. I. Rukovodstvo po issledovaniyu kachestva zhizni v meditsine [Guidebook for medical studies of life quality]. 2nd ed. Moscow: OLMA Media Grupp. 2007.
  2. International Diabetes Federation. IDF Diabetes Atlas, 7th ed. Brussels, Belgium: International Diabetes Federation, 2015.
  3. Shishkova Yu. A., Surkova E. V., Motovilin O. G., Maiorov A. Yu. Sakharnyi diabet. 2011. No. 3. Pp. 70–75.
  4. Rubin R. R., Peyrot M. Diabetes Metab. Res. Rev. 1999. Vol. 15: Pp. 205–218. https://doi.org/10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
  5. Nicolucci A., Kovacs Burns K., Holt R. I. G. Diab. Med. 2013. Vol. 30. Pp. 767–777. https://doi.org/10.1111/dme.12245
  6. Joss N., Patel R., Paterson K. QJM. 2007. Vol. 100. Pp. 641–647. https://doi.org/10.1093/qjmed/hcm080
  7. Bosman D. R., Osborne C. A., Marsden J. T. Diabet. Med. 2002. Vol. 19. Pp. 65–69. https://doi.org/10.1046/j.1464-5491.2002.00634.x
  8. Pchelin I. Yu., Shishkin A. N. Vestnik Sankt-Peterburgskogo universiteta. Seriya 11. Meditsina. 2010. No. 2. Pp. 73–80.
  9. Andro M., Le Squere P., Estivin S., Gentric A. Eur. J. Neurol. 2013. Vol. 20. Pp. 1234–1240. https://doi.org/10.1111/ene.12175
  10. Peuranpää P. Acta Obstet Gynecol Scand. 2014. Vol. 93. Pp. 654–660. https://doi.org/10.1111/aogs.12394
  11. Doehner W., von Haehling S., Anker S. D. Int. J. Cardiol. 2013. Vol. 162. Pp. 67–68. https://doi.org/10.1016/j.ijcard.2012.10.016
  12. Ramos F., Pedro C., Tormo M. Eur. J. Cancer Care. 2016. In print. https://doi.org/10.1111/ecc.12426
  13. Lee Y. J., Kim M. S., Cho S, Kim S. R. Int. J. Clin. Pract. 2013. Vol. 67. Pp. 363–368. https://doi.org/10.1111/ijcp.12020
  14. Okubo R., Kai H., Kondo M. Clin. Exp. Nephrol. 2014. Vol. 18. Pp. 697–703. https://doi.org/10.1007/s10157-013-0901-x
  15. Hsu K. L., Fink J. C., Ginsberg J. S. Am. J. Kidney Dis. 2015. Vol. 66. Pp. 621–629.
  16. Stugiewicz M., Tkaczyszyn M., Kasztura M. Eur. J. Heart Fail. 2016. In print. https://doi.org/10.1002/ejhf.467
  17. Pchelin I. Yu., Shishkin A. N., Korobitsyn L. P. Nefrologiya. 2010. Vol. 14. No. 3. Pp. 32–36.
  18. Michelakos T., Kousoulis A. A., Katsiardanis K. J. Aging Health. 2013. Vol. 25. Pp. 589–616. https://doi.org/10.1177/0898264313482488
  19. Camara M. L., Corrigan F., Jaehne E. J. Psychoneuroendocrinology. 2013. Vol. 38. Pp. 3102–3114. https://doi.org/10.1016/j.psyneuen.2013.09.010
  20. Zhang X., Norris S. L., Gregg E. W. The Diabetes Educator. 2007. Vol. 33. Pp. 273–281. https://doi.org/10.1177/0145721707299265